Coronary Artery Disease News and Research RSS Feed - Coronary Artery Disease News and Research

Coronary artery disease is the most common type of heart disease and the leading cause of death worldwide. It occurs when the arteries that supply blood to the heart become narrowed or blocked by a buildup of "plaque" - cholesterol or other fatty deposits that build on the inner wall of the artery. Over time, this plaque build up results in a reduction of blood flow to the heart, which can cause chest pain. If the artery becomes completely blocked, usually by a blood clot, oxygen is prevented from reaching the heart which can result in a heart attack and/or damage to the heart tissue.
Obesity, other cardiovascular issues to be the focus of Brazilian Congress of Cardiology

Obesity, other cardiovascular issues to be the focus of Brazilian Congress of Cardiology

More than 4,000 extra wide seats were made to accommodate Brazil's increasing obese population during the World Cup this year. Obesity affects nearly 20 percent of the population in Brazil and is currently classified as a disability. This and other cardiovascular issues, such as the overuse of technology, will be the focus of the Brazilian Congress of Cardiology, a joint event with the European Society of Cardiology and the Brazilian Society of Cardiology, 26-29 September. [More]
South Asians in Canada have higher rate of heart disease compared with white people

South Asians in Canada have higher rate of heart disease compared with white people

South Asians living in Canada have a higher rate of heart disease and double the rate of diabetes compared with while people, McMaster researchers have found. [More]
Lobectomy and segmentectomy have similar efficacy in stage I NSCLC

Lobectomy and segmentectomy have similar efficacy in stage I NSCLC

Lobectomy and anatomic segmentectomy appear to offer similar perioperative and oncological outcomes in patients with stage I non-small-cell lung cancer, analysis suggests. [More]
Abbott announces initiation of ABSORB IV heart stent clinical trial

Abbott announces initiation of ABSORB IV heart stent clinical trial

Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. [More]
Researchers develop new methods that improve quality of myocardial perfusion imaging

Researchers develop new methods that improve quality of myocardial perfusion imaging

New methods that enhance the quality of myocardial perfusion imaging were developed in a recent study completed at the University of Eastern Finland. [More]
Researchers uncover intriguing link between heart attacks and protein

Researchers uncover intriguing link between heart attacks and protein

A team of researchers at the University of Ottawa Heart Institute, led by Dr. Alexandre Stewart, have uncovered an intriguing link between heart attacks and a protein that is of great interest to drug companies for its impact on cholesterol. [More]
Measuring levels of sex hormones in patients' blood may identify risk of sudden cardiac arrest

Measuring levels of sex hormones in patients' blood may identify risk of sudden cardiac arrest

Measuring the levels of sex hormones in patients' blood may identify patients likely to suffer a sudden cardiac arrest, a heart rhythm disorder that is fatal in 95 percent of patients. [More]

FFR guided drug-eluting stenting reduces death compared to medical therapy in stable CAD patients

Fractional flow reserve (FFR)-guided drug-eluting stenting reduces death, myocardial infarction or urgent revascularisation, as compared to medical therapy in patients with stable coronary artery disease (CAD), according to the results of the FAME 2 trial presented for the first time today at ESC Congress by principal investigator Dr Bernard De Bruyne (Belgium). [More]
Measuring coronary artery blockage in heart attack patients can help avoid surgery

Measuring coronary artery blockage in heart attack patients can help avoid surgery

A method for measuring coronary artery blockage in heart attack patients can help more than one fifth of them avoid stents or surgery, according to a British study presented at the ESC Congress 2014 today. [More]
Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO (rivaroxaban) to include additional high-risk patient populations. [More]
Philips to highlight full range of cardiology solutions at ESC Congress 2014

Philips to highlight full range of cardiology solutions at ESC Congress 2014

Royal Philips today announced its presence at the European Society of Cardiology Congress 2014, where the company is highlighting the full range of its cardiology solutions serving clinicians and patients across the care continuum from prevention and diagnosis, to treatment, recovery and wellness. [More]
Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting. [More]
Endothelial cells can function as cardiac stem cells to produce new heart muscle tissue

Endothelial cells can function as cardiac stem cells to produce new heart muscle tissue

Endothelial cells residing in the coronary arteries can function as cardiac stem cells to produce new heart muscle tissue, Vanderbilt University investigators have discovered. [More]
Royal Philips receives 510(k) clearance from FDA for TAVI treatments

Royal Philips receives 510(k) clearance from FDA for TAVI treatments

Royal Philips (NYSE: PHG AEX: PHIA) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its precision planning application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. [More]
Researchers find current blood pressure recommendations for older patients

Researchers find current blood pressure recommendations for older patients

Confused about the new blood pressure recommendations and what you should be aiming for? You're not alone. [More]

ASAHI INTECC, Boston Scientific to develop new, differentiated FFR wire

Boston Scientific Corporation and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire. [More]
Cardium announces review in Journal of Cardiovascular Pharmacology finds gene therapy for subset of heart disease patients ‘highly warranted’

Cardium announces review in Journal of Cardiovascular Pharmacology finds gene therapy for subset of heart disease patients ‘highly warranted’

Cardium Therapeutics, an operating unit of Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) has announced the publication of a review article in the Journal of Cardiovascular Pharmacology that concludes a gene therapy product promoting the growth of blood vessels is “highly warranted” to treat about 1 million U.S. heart-disease patients and 6 million more worldwide who are either ineligible or poor candidates for traditional angioplasty, stent placement or bypass surgery. [More]
Patients treated with drug for type 2 diabetes can live longer than people without the condition

Patients treated with drug for type 2 diabetes can live longer than people without the condition

Patients treated with a drug widely prescribed for type 2 diabetes can live longer than people without the condition, a large-scale study involving over 180,000 people has shown. [More]
Diabetes linked to increased head and neck cancer risk

Diabetes linked to increased head and neck cancer risk

People with diabetes mellitus have a significantly increased risk of developing head and neck cancer compared with those without the condition, show results of a large study conducted in Taiwan. [More]
Oral wellness can help save money

Oral wellness can help save money

The American Journal of Preventive Medicine recently published a study from United Concordia Dental that shows reduced hospitalizations and health care costs are possible when individuals with certain chronic conditions, or who are pregnant receive and maintain treatment for gum disease. [More]